Consumer Technology Association: new digital therapeutics standard
The Consumer Technology Association (CTA) has released a new standard for the use of digital therapeutics. DTx comprises an emerging field of medicine that utilizes software-based interventions in order to provide or enhance care.
“The biggest challenge in the digital therapeutics industry is the wide variety of terms used to define it, from digital devices to digital medicine,” said Kerri Haresign, director of technology and standards at CTA. “A clear standard will eliminate industry confusion, making these technologies more widely available for use and adoption. Greater access will lead to better health outcomes for patients. Establishing a common vocabulary allows our industry to focus on the more complex problems, such as evidence-based performance criteria that allow doctors and clinicians to integrate digital therapeutics in their practices.”
